ARTERRA BIOSCIENCE
Milan Stock Exchange ARBS.MI
ARTERRA BIOSCIENCE Gross Profit for the year ending December 31, 2023: USD 1.95 M
ARTERRA BIOSCIENCE Gross Profit is USD 1.95 M for the year ending December 31, 2023, a 270.28% change year over year. Gross profit is the difference between revenue and the cost of revenue, representing the profit earned from core business operations.
-
ARTERRA BIOSCIENCE Gross Profit for the year ending December 31, 2022 was USD 527.23 K, a -31.20% change year over year.
-
ARTERRA BIOSCIENCE Gross Profit for the year ending December 31, 2021 was USD 766.27 K, a 1,934.78% change year over year.
-
ARTERRA BIOSCIENCE Gross Profit for the year ending December 31, 2020 was USD 37.66 K, a -89.67% change year over year.
-
ARTERRA BIOSCIENCE Gross Profit for the year ending December 31, 2019 was USD 364.65 K, a -55.08% change year over year.
Key data
| Date | Gross Profit | Operating Income | EBIT | EBITDA |
|---|
Market news
Loading...
Milan Stock Exchange: ARBS.MI
| CEO | Ms. Maria Gabriella Colucci |
| IPO Date | Oct. 28, 2019 |
| Location | Italy |
| Headquarters | via Benedetto Brin, 69 Napoli, 80142Italy |
| Employees | 34 |
| Sector | Health Care |
| Industries | |
Description
Arterra Bioscience S.p.A., a research-based biotech company, engages in the research and development of various ingredients and natural solutions. It develops technological platforms, extraction processes, and raw materials for use in the cosmetics, agriculture, and nutraceutics sectors. Arterra Bioscience S.p.A. was founded in 2003 and is based in Naples, Italy.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email